Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 17026 - 17050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Ciglitazone	Experimental	LMCD1	29995	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of LMCD1 mRNA	3p25.3	A21647
Ciglitazone	Experimental	LOX	4015	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of LOX mRNA	5q23.1	A21647
Ciglitazone	Experimental	LPCAT1	79888	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of LPCAT1 mRNA	5p15.33	A21647
Ciglitazone	Experimental	LPCAT3	10162	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of LPCAT3 mRNA	12p13.31	A21647
Ciglitazone	Experimental	MAGED4	728239	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of MAGED4 mRNA	Xp11.22	A21647
Ciglitazone	Experimental	MAGED4B	81557	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of MAGED4B mRNA	Xp11.22	A21647
Ciglitazone	Experimental	MAP4K3	8491	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of MAP4K3 mRNA	2p22.1	A21647
Ciglitazone	Experimental	MAPK14	1432	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of MAPK14 mRNA	6p21.31	A21647
Ciglitazone	Experimental	MKI67	4288	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of MKI67 mRNA	10q26.2	A21647
Ciglitazone	Experimental	MPC1	51660	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of MPC1 mRNA	6q27	A21647
Ciglitazone	Experimental	MPZL2	10205	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of MPZL2 mRNA	11q24	A21647
Ciglitazone	Experimental	MTMR4	9110	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of MTMR4 mRNA	17q22	A21647
Ciglitazone	Experimental	NDRG2	57447	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of NDRG2 mRNA	14q11.2	A21647
Ciglitazone	Experimental	NPC1	4864	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of NPC1 mRNA	18q11.2	A21647
Ciglitazone	Experimental	NR1H3	10062	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of NR1H3 mRNA	11p11.2	A21647
Ciglitazone	Experimental	NREP	9315	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of NREP mRNA	5q22.1	A21647
Ciglitazone	Experimental	OAS1	4938	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of OAS1 mRNA	12q24.2	A21647
Ciglitazone	Experimental	OAS1	4938	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of OAS1 mRNA	12q24.2	A21647
Ciglitazone	Experimental	OPTN	10133	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of OPTN mRNA	10p13	A21647
Ciglitazone	Experimental	OPTN	10133	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of OPTN mRNA	10p13	A21647
Ciglitazone	Experimental	OSMR	9180	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of OSMR mRNA	5p13.1	A21647
Ciglitazone	Experimental	PALM2	114299	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PALM2 mRNA	9q31.3	A21647
Ciglitazone	Experimental	PALM2-AKAP2	445815	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PALM2-AKAP2 mRNA	9q31.3	A21647
Ciglitazone	Experimental	PCK1	5105	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PCK1 mRNA	20q13.31	A21647
Ciglitazone	Experimental	PCK1	5105	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of PCK1 mRNA	20q13.31	A21647

Displaying entries 17026 - 17050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability